141 related articles for article (PubMed ID: 33419525)
1. Stress and strain on the U.S. drug supply: The intersection of shortages, globalization, counterfeit products, and throw in a global COVID-19 pandemic.
Farmer KC
J Am Pharm Assoc (2003); 2021; 61(1):e85-e86. PubMed ID: 33419525
[No Abstract] [Full Text] [Related]
2. Drugs, drugs--who has the drugs?
Blair J
J Healthc Prot Manage; 2012; 28(1):28-32. PubMed ID: 22423518
[TBL] [Abstract][Full Text] [Related]
3. Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.
Mackey TK; Liang BA; York P; Kubic T
Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):59-67. PubMed ID: 25897059
[TBL] [Abstract][Full Text] [Related]
4. Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future.
Kuo S; Ou HT; Wang CJ
J Am Pharm Assoc (2003); 2021; 61(1):e12-e15. PubMed ID: 32919923
[TBL] [Abstract][Full Text] [Related]
5. Counterfeit drugs: an Australian perspective.
Hensey CC; Gwee A
Med J Aust; 2016 May; 204(9):344. PubMed ID: 27169964
[No Abstract] [Full Text] [Related]
6. A review of existing and emerging digital technologies to combat the global trade in fake medicines.
Mackey TK; Nayyar G
Expert Opin Drug Saf; 2017 May; 16(5):587-602. PubMed ID: 28349715
[TBL] [Abstract][Full Text] [Related]
7. IOM: Curbing fake drugs will require national tracking and global teamwork.
Kuehn BM
JAMA; 2013 Apr; 309(13):1333-4. PubMed ID: 23549559
[No Abstract] [Full Text] [Related]
8. [Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].
Furman-Assaf S; Tamir O; Marom E; Arieli M; Shemer J
Harefuah; 2010 Jul; 149(7):470-5, 479. PubMed ID: 21465764
[TBL] [Abstract][Full Text] [Related]
9. Strengthening global action against poor quality drugs.
Lancet; 2013 Feb; 381(9867):599. PubMed ID: 23439085
[No Abstract] [Full Text] [Related]
10. Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.
't Hoen E; Pascual F
J Public Health Policy; 2015 Nov; 36(4):384-9. PubMed ID: 26178809
[TBL] [Abstract][Full Text] [Related]
11. It Takes a Village…: Contending With Drug Shortages During Disasters.
Burry LD; Barletta JF; Williamson D; Kanji S; Maves RC; Dichter J; Christian MD; Geiling J; Erstad BL
Chest; 2020 Dec; 158(6):2414-2424. PubMed ID: 32805237
[TBL] [Abstract][Full Text] [Related]
12. Medicines counterfeiting is a complex problem: a review of key challenges across the supply chain.
Tremblay M
Curr Drug Saf; 2013 Feb; 8(1):43-55. PubMed ID: 23656447
[TBL] [Abstract][Full Text] [Related]
13. Stemming the global trade in falsified and substandard medicines.
Gostin LO; Buckley GJ; Kelley PW
JAMA; 2013 Apr; 309(16):1693-4. PubMed ID: 23579391
[No Abstract] [Full Text] [Related]
14. National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages.
Piatek OI; Ning JC; Touchette DR
Am J Health Syst Pharm; 2020 Oct; 77(21):1778-1785. PubMed ID: 32716030
[TBL] [Abstract][Full Text] [Related]
15. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies.
Badreldin HA; Atallah B
Res Social Adm Pharm; 2021 Jan; 17(1):1946-1949. PubMed ID: 32446652
[TBL] [Abstract][Full Text] [Related]
16. The Medicines Quality Database: a free public resource.
Krech LA; El-Hadri L; Evans L; Fouche T; Hajjou M; Lukulay P; Phanouvong S; Pribluda V; Roth L
Bull World Health Organ; 2014 Jan; 92(1):2-2A. PubMed ID: 24391291
[No Abstract] [Full Text] [Related]
17. Counterfeit drugs pose growing health threat.
Traynor K
Am J Health Syst Pharm; 2010 Nov; 67(22):1896, 1898. PubMed ID: 21048204
[No Abstract] [Full Text] [Related]
18. World's drug supply chain needs better oversight, FDA says.
Traynor K
Am J Health Syst Pharm; 2009 Jan; 66(1):12-3. PubMed ID: 19106338
[No Abstract] [Full Text] [Related]
19. Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic.
Cundell T; Guilfoyle D; Kreil TR; Sawant A
PDA J Pharm Sci Technol; 2020; 74(4):468-494. PubMed ID: 32467176
[TBL] [Abstract][Full Text] [Related]
20. Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.
Liberman J
J Law Med Ethics; 2012; 40(2):326-47. PubMed ID: 22789049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
